{{Rsnum
|rsid=1376877
|Gene=ABI2
|Chromosome=2
|position=203407367
|Orientation=plus
|GMAF=0.3829
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=ABI2
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 21.4 | 48.2 | 30.4
| HCB | 59.6 | 33.8 | 6.6
| JPT | 51.8 | 42.7 | 5.5
| YRI | 79.6 | 19.0 | 1.4
| ASW | 66.7 | 31.6 | 1.8
| CHB | 59.6 | 33.8 | 6.6
| CHD | 57.4 | 36.1 | 6.5
| GIH | 14.0 | 39.0 | 47.0
| LWK | 59.1 | 36.4 | 4.5
| MEX | 26.3 | 52.6 | 21.1
| MKK | 54.2 | 38.1 | 7.7
| TSI | 18.6 | 46.1 | 35.3
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs1376877
|PubMedID=17903303
|Condition=Other subclinical atherosclerosis traits
|Gene=ABI2
|Risk Allele=
|pValue=4.00E-007
|OR=NA
|95CI=
|OA=1
}}

{{PharmGKB
|RSID=rs1376877
|Name_s=
|Gene_s=ABI2
|Feature=
|Evidence=PubMed ID:17903303; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS results: Genome-wide association study for subclinical atherosclerosis in major arterial territories in the NHLBI's Framingham Heart Study (Initial Sample Size: 673-984 individuals, depending on measure (Framingham; Replication Sample Size: NR). This variant is associated with Other subclinical atherosclerosis traits.
|Drugs=
|Drug Classes=
|Diseases=Arteriosclerosis; Cardiovascular Diseases; Coronary Disease
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356502
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1376877
|overall_frequency_n=55
|overall_frequency_d=128
|overall_frequency=0.429688
|n_genomes=32
|n_genomes_annotated=0
|n_haplomes=43
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}